Special Bulletin
The American Hospital Association (AHA) sends members Special Bulletins on the latest health care news, legislation, and advocacy opportunities for hospitals and health systems.
The AHA will host a call today, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies.
The AHA will host a call on Monday, Nov. 16, from 4-5 p.m. ET with leaders from the Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR) and other federal agencies to discuss the delivery and administration of monoclonal antibody therapies…
The Centers for Medicare & Medicaid Services (CMS) Nov. 9 released a final rule revising its Medicaid and Children’s Health Insurance Program (CHIP) managed care regulations that implement policy changes to streamline existing manage care regulations as recommended by state Medicaid directors.
With the COVID-19 pandemic reaching the point in which vaccines against the coronavirus may soon be publicly available, the AHA is helping hospitals and health systems prepare for their arrival, while promoting public confidence in Food and Drug Administration-approved SARS-CoV-2 vaccines.
The Food and Drug Administration Nov. 10 issued an emergency use authorization (EUA) for Eli Lilly and Company’s monoclonal antibody therapy, bamlanivimab. The EUA authorizes the product’s use, but only in outpatient settings; additionally, it sets forth the type of patients eligible to receive the…
In anticipation of the likely issuance of emergency use authorizations (EUAs) for at least two monoclonal antibody therapeutic drugs developed to treat certain COVID-19 positive patients, Operation Warp Speed released an initial playbook to assist providers in planning. The playbook lays out…
The AHA Nov. 10, at 2 p.m. ET will host an all-member live virtual advocacy event.
The Department of Health and Human Services issued an important clarification to its Oct. 22 reporting requirements for providers that received Provider Relief Fund payments.
In anticipation of the likely issuance of emergency use authorizations (EUAs) for at least two monoclonal antibody therapeutic drugs developed to treat certain COVID-19 positive patients, providers should begin planning for the distribution and administration process of these therapeutics.
The Centers for Medicare & Medicaid Services (CMS) Oct. 29 issued a final rule to update the home health (HH) prospective payment system for calendar year (CY) 2021.